Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net product sales	$ 832,100	$ 930,449	$ 1,712,275	$ 1,257,505
Operating expenses:
Cost of goods sold	$ 89,775	$ 58,435	$ 180,310	$ 191,439
Cost, Product and Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Research and development	$ 40,388	$ 81,699	$ 273,582	$ 554,753
Selling, general and administrative	2,614,488	2,635,161	7,334,738	7,115,605
Total operating expenses	2,744,651	2,775,295	7,788,630	7,861,797
Loss from operations	(1,912,551)	(1,844,846)	(6,076,355)	(6,604,292)
Other income (expense):
Forgiveness of paycheck protection loan and accrued interest				105,130
Interest income	24,714	1,421	29,419	7,596
Interest expense	(126,027)	(126,027)	(373,973)	(374,024)
Total other income (expense)	(101,313)	(124,606)	(344,554)	(261,298)
Net loss	$ (2,013,864)	$ (1,969,452)	$ (6,420,909)	$ (6,865,590)
Net loss per share of common stock, basic	$ (0.60)	$ (0.73)	$ (2.09)	$ (2.57)
Net loss per share of common stock, diluted	$ (0.60)	$ (0.73)	$ (2.09)	$ (2.57)
Weighted-average shares used to compute basic net loss per share	3,343,070	2,711,871	3,077,145	2,669,070
Weighted-average shares used to compute diluted net loss per share	3,343,070	2,711,871	3,077,145	2,669,070